Using genomics in medicine
Contributions of the Alzheimer’s Disease Neuroimaging Initiative to advancing AD research: A targeted review of recent publications
Navigating data sharing in research
Rare Disease Day at NIH 2026: Paving the Way to a Brighter Future for All Americans
In celebration of 2026 Rare Disease Day, nearly 2,300 researchers, clinicians, patients, and advocates filled the halls of the NIH Natcher Conference Center or joined virtually to highlight the urgency and opportunity of advancing rare disease research. With more than 10,000 identified rare diseases affecting millions of Americans, speakers emphasized the need for innovative trial … Continued
Newborn Genomic Screening Takes Center Stage at ACMG as Stakeholders Discuss Progress, Concerns
As newborn genomic screening initiatives continue to unfold around the world, the ethical and responsible implementation of the approach into public health sparked vibrant discussions at the American College of Medical Genetics and Genomics (ACMG) annual meeting last week. In addition to updates from notable newborn genomic screening studies — such as the UK’s Generation … Continued
Genetic findings and healthcare utilization among individuals undergoing population genomic screening for actionable hereditary disorders
Designing inclusive newborn sequencing research: Insights from parents in underrepresented communities
Navigating ethical, legal and social implications in genomic newborn screening
BEACONS Newborn Genome Screening Study Selects Seven Sites, Finalizes Gene List
GenomeWeb celebrates the BEACONS team’s announcement regarding the selection of 7 U.S. states and territories selected to assess the feasibility of integrating whole genome sequencing into public health newborn screening. The team also published the curated gene list, which consists of 746 genes associated with 777 genetic conditions, all clinically actionable within the first year … Continued
BEACONS Selects Seven Sites, Finalizes Gene List for Genomic Newborn Screening Study
Ariadne Labs covers the announcement of two major milestones from the newly NIH-funded study, BEACONS. Six states and one U.S. territory have been selected to assess feasibility of integrating whole genome sequencing into public health newborn screening. The BEACONS team has also published the curated gene list, consisting of 777 genetic conditions, all actionable within … Continued
Genomic risk model to implement precision prostate cancer screening in clinical care: theProGRESS study
Nationwide genetic screening proves effective at catching disease risk early
This Nature article highlights how nationwide genetic screening shows promise for early disease risk detection. Evidence from a large Australian pilot demonstrates population-wide genetic screening in young adults can successfully identify individuals at increased risk for serious heritable conditions, including hereditary cancers and high cholesterol, before symptoms arise. The findings outline the potential of early … Continued
Feasibility and outcomes of the DNA Screen nationwide adult genomic screening pilot
Genomic newborn screening: A scoping review of the field’s evolution and associated ethical, legal, and social implications
Study: Major Gaps Block Genetics Evaluation and Testing for Black and Low Income Patients
This press release describes crucial findings from a joint study by the Perelman School of Medicine at the University of Pennsylvania and Massachusetts General Hospital. The research team highlights systemic obstacles in primary care, lack of referral guidelines, and workforce shortages, and they call for interventions like decision-support flags in electronic health records, embedded genetic … Continued
Explore 2025’s Most Impactful Genetics Research
Join us in celebrating Nina Gold and her team’s incredible work investigating the sensitivity of genomic newborn screening for treating inherited metabolic conditions. Editor-in-Chief Robert D. Steiner of Genetics in Medicine recognized this work as one of the most impactful pieces of genetics research published in 2025!
Dr. Robert Green Speaks at TED on Bringing Preventive Genomics into Everyday Care
Ariadne Labs celebrates Dr. Robert Green’s TED Talk, which explores how preventive genomics could transform medicine by identifying disease risk before symptoms ever appear, even from birth. Drawing on the world’s first DNA screening of healthy newborns, he makes the case for a future of care focused on prediction and prevention, not just treatment.
The Double-Edged Code: The promise and peril of personal genomics
This article explores the critical transition toward genomic implementation into precision health, examining the economic, clinical, and ethical frameworks required to integrate genomic data into everyday care. Featuring insights from G2P Director Dr. Robert Green and other leading experts, it challenges us to consider how we will responsibly navigate the most intimate information we possess.
Can Genomic Sequencing at Birth Transform Medicine? Reflections from My TED Talk
In this blog post, Dr. Green reflects on his mainstage TED Talk, making the case that integrating whole-genome sequencing at birth could reveal thousands of treatable genetic risks early in life. Drawing on findings from BabySeq Project and the newly funded BEACONS Initiative, he shows how a single test at birth could give families actionable … Continued
APHL Convenes Newborn Whole Genome Sequencing Initiative, Ensuring Public Health Laboratory Input
APHL celebrates the launch of BEACONS, the nation’s first multi-state initiative evaluating whether whole genome sequencing (WGS) can be responsibly integrated into the U.S. newborn screening system. With a $14.4M NIH award and invaluable participation from public health labs across the country, BEACONS will test how WGS affects workflows, consent, data systems, and the actionable … Continued
The Future of Veteran Health: Dr. Jason Vassy on genomic medicine
In this episode, Dr. Jason Vassy explains how genomic tools are transforming Veteran health, from tailoring medications using DNA to improving prostate cancer screening. Drawing on VA-wide research efforts like MVP and the PROGRESS Study, he shows what personalized, preventive care could look like in the years ahead.
Genetics and context for precision health in Greater Boston
A Spectacular, Fashion-filled Night in Doha: Inside the Inaugural Franca Fund Gala
The inaugural Franca Fund Gala, held at Doha’s Museum of Islamic Art and hosted by Anna Wintour alongside Francesco Carrozzini and H.E. Sheikha Al Mayassa, celebrated the legacy of Franca Sozzani while raising over $4 million to support Dr. Robert Green’s pioneering work in preventive genomics. Proceeds from the evening directly advance the Franca Fund’s … Continued
A lack of information about family health history motivates adopted individuals to pursue elective genomic testing
Genetics and context for precision health in greater Boston
Governance strategies for biological AI: Beyond the dual-use dilemma
NIH Funds Multi-State Pilot For Genome Sequencing in Newborn Screening
Dr. Green describes the impact of the novel, NIH-funded BEACONS study: “For more than 50 years, newborn screening has been a beacon of trust, saving children’s lives by analyzing a few drops of blood after birth. BEACONS brings the next generation of hope, giving families the option of genomic screening for hundreds of additional conditions … Continued
First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award
Funded by a $14.4 million award from the National Institutes of Health (NIH) Common Fund Venture Program, BEACONS will pilot the integration of whole genome sequencing into existing state newborn screening systems. The study will recruit, consent, and enroll up to 30,000 newborns in as many as 10 states over the next three years, a … Continued
GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award
GeneDx has launched the first multi-state national genomic newborn screening initiative, supported by a $14.4 million award from the National Institutes of Health Common Fund Venture Program. The effort, part of the BEACONS project, will enroll thousands of newborns to study how whole genome sequencing could be integrated into standard public health newborn screening systems.
NIH Makes $14.4 Million Award to Launch Initiative to Bring WGS to Newborn Screening
Global Genes celebrates the latest NIH award of $14.4 million to launch a pioneering initiative aimed at integrating whole genome sequencing (WGS) into newborn screening programs, with the goal of improving early detection of rare and treatable conditions.
Are inherited metabolic disorders more common and less predictable than we thought?
The NIH Venture Program Announces First Award for the NBSxWGS (BEACONS) Initiative
The NIH Common Fund’s Venture Program has announced the first award for the NBSxWGS (BEACONS) initiative, a multi-institutional effort to assess the feasibility of integrating whole genome sequencing into U.S. public health newborn screening programs. BEACONS brings together academic leaders, public health laboratories, sequencing partners, and community stakeholders to explore how genomic screening could identify … Continued
G2P Summer Newsletter 2025
What better way to lounge around, enjoying the dog days, than to catch up on G2P news? In this newsletter, G2P presents several summer reads (and a listen!), exploring the various ways genomics is shaping the future of healthcare—and what it means for all of us. Also, come join us at the 2025 Annual Meeting … Continued
Riskier to know — or not to know — you’re predisposed to a disease?
‘DNA isn’t a crystal ball for every kind of illness’ but potential benefits outweigh fears, says geneticist, Robert C. Green, MD, MPH.
The Ethical Minefield of Testing Infants for Incurable Diseases
When Dr. Robert C. Green began BabySeq in 2013, it was the first program in the world to sequence healthy babies, and it was “totally radioactive,” he said. Screening can determine their risk for an ever-growing list of conditions — including ones we can’t do much about.

















